glp 1 and blindness Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 Medications Study Links GLP-1 Drugs to

The most common injection sites include the upper arm (deltoid muscle), thigh (vastus lateralis muscle), buttocks (gluteal muscle), and hip (ventrogluteal muscle)

Global antimicrobial resistance and use surveillance system (GLASS) report

Absolutely, to lock in hydration

The Acetyl-CoA generated from ALCAR is a crucial building block for these structural lipids

What to track Symptoms log: Hot flash frequency and severity Sleep quality (hours, quality 1-10) Energy levels daily Mood and anxiety Brain fog incidents Period timing (if still menstruating) Body composition: Weight weekly (understanding fluctuations normal) Body measurements (waist, hips) Photos every 2-4 weeks How clothes fit Muscle vs fat changes Hormone-related: Menstrual cycle length and flow PMS symptoms Breast tenderness Libido changes Vaginal dryness Quality of life: Exercise performance Work productivity Relationship satisfaction Social engagement Overall well-being Bloodwork for perimenopause peptides Baseline testing: Estradiol (estrogen) Progesterone Testosterone (total and free) FSH (follicle-stimulating hormone - elevated in perimenopause) Thyroid panel (TSH, Free T3, Free T4) IGF-1 (growth hormone marker) Fasting glucose and insulin Lipid panel Follow-up (every 3-6 months): IGF-1 (should increase with GH peptides) Thyroid panel Fasting glucose Hormones if on HRT Adjusting based on results: Low IGF-1 still

Post-treatment soreness is usually mild and temporary